HLS Therapeutics (OTCMKTS:HLTRF) Shares Break Below 200 Day Moving Average – Time to Sell?

Shares of HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) crossed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $3.09 and traded as low as $2.73. HLS Therapeutics shares last traded at $2.73, with a volume of 100 shares trading hands.

Wall Street Analyst Weigh In

Separately, Raymond James Financial raised HLS Therapeutics from an “outperform” rating to a “strong-buy” rating in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating. According to data from MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

Read Our Latest Report on HLS Therapeutics

HLS Therapeutics Trading Down 14.7%

The company’s 50-day simple moving average is $2.87 and its 200-day simple moving average is $3.09.

About HLS Therapeutics

(Get Free Report)

HLS Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, licensing, developing and commercializing prescription medicines. Rather than primarily discovering new drugs, the company generally builds value by obtaining rights to established or differentiated pharmaceutical products and supporting their regulatory approval, market access and commercial distribution. The company’s activities have centered on specialty-care and hospital-related therapies, including products for central nervous system and cardiovascular conditions.

Recommended Stories

Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.